TrialScandinavian journal of gastroenterology2016

Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience.

Jesper Waldenström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.